The Dutch company, ViCentra, announced the Kaleido insulin pump will soon work with Diabeloop’s newest DBLG2 algorithm and gain Dexcom G7 support—bringing fully smartphone-based control to its hybrid closed loop system. That’s right - no more PDM is needed to control the insulin pump.

If you’ve been following our coverage of Kaleido, you know that we think it’s one of the prettiest pumps out there. ViCentra’s colorful pump has always been about design and user experience. The device attaches to the body similar to the Tandem Mobi — using an adhesive patch, with insulin delivered through a short tube connected to a nearby infusion site.

Up until now, Kaleido users have been running on Diabeloop’s first-gen DBLG1 algorithm with Dexcom G6, which required carrying an extra controller. With DBLG2 and G7 integration, insulin automation is handled right from your phone. That means less gear, a sleeker system, and a setup that feels far more “2026” than “2016.”

ViCentra plans to launch first in Germany and the Netherlands in early 2026, starting with a real-world rollout this fall to gather user and clinician feedback before the full commercial debut. And while that’s still a little while away, it’s hard not to see this as the start of a major shift.

Which brings us to - Kaleido 2. Its next-gen pump promises even more refinements including a 10% smaller design, USB-C charging, and an accelerometer, which could potentially be used to track physical activity. It’s exciting days for next-gen insulin pumps and ViCentra is positioning itself to become one of the most user-friendly closed loop systems out there.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.